Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer (Jul, 10.1038/s43018-022-00400-2, 2022)
NATURE CANCER（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined